| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/11/2004 | WO2003059946A3 Genetic polymorphisms predicting cardiovascular disease and medication efficacy |
| 03/11/2004 | WO2003059395A3 Antisense compounds directed against human csf-1 |
| 03/11/2004 | WO2003059386A3 Prion protein carrier-conjugates |
| 03/11/2004 | WO2003057824A3 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003055908A3 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition |
| 03/11/2004 | WO2003046572A3 Biopolymer markers predictive of alzheimers disease |
| 03/11/2004 | WO2003046183A3 Streptococcus suis avirulent vaccine and uses in antibiotic design |
| 03/11/2004 | WO2003045985A3 Purified polypeptides involved in carbohydrate and coenzyme metabolism |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |
| 03/11/2004 | WO2003038441A3 Screening methods based on cited family proteins |
| 03/11/2004 | WO2003033535A3 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 03/11/2004 | WO2003031603A8 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/11/2004 | WO2003030639A3 Methods for growing and imprinting fish using an odorant |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003025223A3 Improvements in or relating to insecticide screening |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003025005A3 Purified bacterial polypeptides involved in protein processing |
| 03/11/2004 | WO2003020213A3 Methods and compositions for treating inflammatory disorders |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003018763A3 Modulation of appl expression |
| 03/11/2004 | WO2003015500A3 Methods for the identification of inhibitors of phytochrome e expression or activity in plants |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2003004646A3 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 03/11/2004 | WO2003004600A3 Improvement of viral uptake into cells and tissues |
| 03/11/2004 | WO2002101026A8 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/11/2004 | WO2002096349A3 Vaccination against the feline immunodeficiency virus |
| 03/11/2004 | WO2002095004A3 Foamy virus mutant reverse transcriptase |
| 03/11/2004 | WO2002094008A3 Transgenic plants protected against parasitic plants |
| 03/11/2004 | WO2002083856A3 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002081654A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002079434A3 Transgenic mice containing kir3.3 potassium channel gene disruptions |
| 03/11/2004 | WO2002079426A3 Transgenic mice containing pai3 serine protease inhibitor gene disruptions |
| 03/11/2004 | WO2002074919A3 Protein-protein interactions |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | WO2002070661A3 Identification and characterization of a waxy curled leaf phenotype (wcl1) in arabidopsis |
| 03/11/2004 | WO2002068602A3 Methods for modulating g2a receptor activity |
| 03/11/2004 | WO2002060923A3 B-superfamily conotoxins |
| 03/11/2004 | US20040049809 Pear genes codifying for beta-galactosidase,pectin methylesterse, polygalacturonase, expansins and their use |
| 03/11/2004 | US20040049804 Maize defense-inducible genes and their use |
| 03/11/2004 | US20040049803 Metallothionein (MTI) and glutamine synthatase (GS) promoters capable of promoting the senescence-associated expression of nucleic acid coding sequences |
| 03/11/2004 | US20040049800 Rapid methods for assessing therapeutic activity using animals expressing constitutively active G protein coupled receptors |
| 03/11/2004 | US20040049150 Vaccines |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049025 Recombinant viral nucleic acids |
| 03/11/2004 | US20040049024 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040049021 Compositions and mehtods for treatment of Hepatitis C virus-associated diseases |
| 03/11/2004 | US20040049018 For inhibiting HIV virus |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040049013 Protein extraction from canola oil seed meal |
| 03/11/2004 | US20040049012 Extracting a target protein from E. coli cells by lowering the pH of a whole E. coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating debris from the protein |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040049010 Transmembrane proteins |
| 03/11/2004 | US20040049009 Aligning the amino acid sequences of antagonists/agonists of CRFR which differ in their antagonistic/agonistic properties, identifying position wherein the amino acid sequences are different, replacing the different amino acids |
| 03/11/2004 | US20040048821 Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene |
| 03/11/2004 | US20040048817 Methods of immunotherapy and diagnosis |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048800 Use of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 03/11/2004 | US20040048799 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048793 Therapeutic peptide-based constructs |
| 03/11/2004 | US20040048792 Antimicrobial peptides and methods of use thereof |
| 03/11/2004 | US20040048790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 03/11/2004 | US20040048781 Introducing into phagocytic cells that are in contact with immune complexes an inhibitor of a kinase endogenous to said cells associated with an Fc receptor present at the membrane of said cells |
| 03/11/2004 | US20040048378 Genetic manipulation of homologous recombination in meiosis and mitosis. |
| 03/11/2004 | US20040048377 Methods and compositions involved in groucho-mediated differentiation |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048341 Vascular endothelial growth factor (VEGF) molecule and process for producing same |
| 03/11/2004 | US20040048340 Apoptosis Inducing Molecule-1 (AIM-I) polypeptides useful in biological, diagnostic, clinical or therapeutic arts |
| 03/11/2004 | US20040048339 Human proteins having transmembrane domains and cDNAs encoding these proteins |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048332 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048321 Comprises (poly)peptides synthesized to match telopeptide components of type III collagen degradation products in body fluids; immunogens; antigens |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048315 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof |
| 03/11/2004 | US20040048314 Novel physiologically active peptide and use thereof |
| 03/11/2004 | US20040048312 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 03/11/2004 | US20040048307 Cell growth differentiation factors; for detecting increased muscle mass in food animals; kits |
| 03/11/2004 | US20040048304 95 human secreted proteins |
| 03/11/2004 | US20040048303 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/11/2004 | US20040048298 An endogenous nucleic acid fragment of the retroviral type, integrated into the DNA of the human genome |
| 03/11/2004 | US20040048296 Human tumor necrosis factor TR20 and methods based thereon |
| 03/11/2004 | US20040048295 Screening methods for identifying agonists and antagonists of hereulin -like factor (HLF) activity; diagnostic methods for detecting disorders of the regulation of cell growth and therapeutic methods for treating disorders of the regulation |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048285 Nucleotide and amino acid sequences of several G protein coupled receptors |
| 03/11/2004 | US20040048284 Novel g protein-coupled receptor protein and dna thereof |